Lidocaine on Pain Relief and IL and Substance P in Fibromyalgia
Status:
Unknown status
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The study's primary objective is to evaluate the effect of intravenous lidocaine on pain and
plasma interleukin-1 (IL-1), interleukin-6 (IL-6) and substance P in patients with
fibromyalgia.
As secondary objectives: evaluate the clinical manifestations, and plasma concentration of
lidocaine.
Phase:
Phase 3
Details
Lead Sponsor:
Federal University of São Paulo
Treatments:
Acetaminophen Amitriptyline Amitriptyline, perphenazine drug combination Analgesics Lidocaine Neurokinin A Pharmaceutical Solutions Polystyrene sulfonic acid Substance P Tramadol